Pipeline — registered trials by phase
PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine
— · Lung Cancer, Ovarian Cancer, Uterine Cancer · Completed · est. 2024-12-31
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Labcorp is lead sponsor; 1 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-09-30Current report (material event)
- 8-K2026-09-22Current report (material event)
- 8-K2026-09-10Current report (material event)
- 8-K2026-08-28Current report (material event)
- 8-K2026-08-17Current report (material event)
- 8-K2026-08-14Current report (material event)
- 10-Q2026-08-05Quarterly report
- 8-K2026-07-30Current report (material event)
- 8-K2026-07-10Current report (material event)
- 8-K2026-06-30Current report (material event)
- 8-K2026-05-27Current report (material event)
- 8-K2026-05-26Current report (material event)
- SD2026-05-22SD
- 10-Q2026-05-04Quarterly report
- 8-K2026-04-30Current report (material event)
- SCHEDULE 13G2026-04-28SCHEDULE 13G
- ARS2026-04-10Annual report to holders
- DEFA14A2026-04-10DEFA14A
- DEF 14A2026-04-10Proxy statement
- 8-K2026-04-09Current report (material event)
- 8-K2026-03-31Current report (material event)
- SCHEDULE 13G/A2026-03-26SCHEDULE 13G/A
- 8-K2026-03-20Current report (material event)
- 10-K2026-02-24Annual report
- 8-K2026-02-17Current report (material event)
- 8-K2026-02-09Current report (material event)
- 8-K2026-01-29Current report (material event)
- 8-K2026-01-15Current report (material event)
- 8-K2026-01-14Current report (material event)
- 8-K2025-12-30Current report (material event)
- 8-K2025-12-15Current report (material event)
- 8-K2025-12-10Current report (material event)
- 8-K2025-11-24Current report (material event)
- 10-Q2025-10-31Quarterly report
- 8-K2025-10-28Current report (material event)
- 8-K2025-10-08Current report (material event)
- 8-K2025-09-25Current report (material event)
- 8-K2025-08-28Current report (material event)
- 10-Q2025-08-01Quarterly report
- 8-K2025-07-24Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.